Eli Lilly to buy Ventyx Biosciences for $1.2bn
MLex Summary: Eli Lilly and Company is proposing to acquire Ventyx Biosciences, Inc. in a deal worth approximately $1.2 billion, the companies announced Wednesday. Ventyx's pipeline of small molecule therapeutics that...To view the full article, register now.
Already a subscriber? Click here to view full article